For condition: Chronic Spontaneous Urticaria
For condition: Urticaria
Research Trial for Chronic Spontaneous Urticaria 1 (72 Weeks)-CA
Study Summary
Who Can Participate?
Males or females, ≥ 18 years of age with chronic spontaneous urticaria (CSU) may be eligible to participate.
Inclusion Criteria:
-
-
- Diagnosis of CSU for 6 months or more
- CSU resistant to a stable dose and regimen containing a second-generation H1 antihistamine (H1AH), as defined by the following:
- Recurrent pruritic wheals (itchy bumps) with or without angioedema (swelling in deeper layers of skin) for ≥ 6 weeks at any time prior to screening despite treatment with a H1AH
- Must have been on a stable dose and regimen containing a second-generation H1AH at approved or increased dose as background therapy for the treatment of CSU for ≥ 4 weeks prior to randomization
-
Participant Info:
-
-
- No cost to participate or receive treatment
- Regular visits with study doctors who specialise in treating chronic spontaneous urticaria
- Will receive investigational injected treatment (active study drug) or placebo
- Reimbursement for study-related expenses may be provided
-
How Long Will The Study Last?
-
-
- 72 weeks (19 study visits)
-
For more information about this trial, please visit ClinicalTrials.gov
